Price target
164.260.000.00%
The 16 analysts offering 1 year price forecasts for J7Z have a max estimate of — and a min estimate of —.
Analyst rating
Based on 19 analysts giving stock ratings to J7Z in the past 3 months.
EPS
0.00
Reported
Estimate
Reported
Estimate
Surprise
Revenue
0.00
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
J7Z EPS for the last quarter is 5.94 EUR despite the estimation of 4.94 EUR. In the next quarter EPS is expected to reach 5.62 EUR. Track more of JAZZ PHARMACEUTICALS PLC financials and stay on top of what is up with the company.
In the next quarter JAZZ PHARMACEUTICALS PLC revenue is expected to reach 1.01 B EUR. Check out JAZZ PHARMACEUTICALS PLC revenue and earnings and make informed decisions.
According to analysts, J7Z price target is 164.26 EUR with a max estimate of 214.59 EUR and a min estimate of 112.89 EUR. Check if this forecast comes true in a year, meanwhile watch JAZZ PHARMACEUTICALS PLC stock price chart and keep track of the current situation with J7Z news and stock market news.
We've gathered opinions of 19 analysts rating J7Z stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.